(Q34995010)

5 August 2017

1 reference

title

Environmental factors in Parkinson's disease (English)

1 reference

5 August 2017

1 reference

Donato A Di Monte

1

1 reference

5 August 2017

Mitra Lavasani

series ordinal

2

1 reference

5 August 2017

Amy B Manning-Bog

series ordinal

3

1 reference

5 August 2017

publication date

1 October 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

23

1 reference

5 August 2017

issue

4-5

1 reference

5 August 2017

page(s)

487-502

1 reference

Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Cigarette smoking and Parkinson disease: 1. Comparison of cases with matched neighbors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Acute and reversible parkinsonism due to organophosphate pesticide intoxication: five cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

2-deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. Implications for neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Catecholamine-derived tetrahydroisoquinolines: O-methylation patterns and regional brain distribution following intraventricular administration in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Diorthosubstituted polychlorinated biphenyls in caudate nucleus in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Single case study. Possible organophosphate-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Decreased ferritin levels in brain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Glutathione in Parkinson's disease: a link between oxidative stress and mitochondrial damage?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Dopamine uptake inhibitory capacities of beta-carboline and 3,4-dihydro-beta-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Parkinsonism and occupational exposure to pesticides

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Nutritional and occupational factors influencing the risk of Parkinson's disease: a case-control study in southeastern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Chronic exposure to the fungicide maneb may produce symptoms and signs of CNS manganese intoxication.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Parkinson's disease and brain levels of organochlorine pesticides

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Inhibition of monoamine oxidase B in the brains of smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Brain monoamine oxidase A inhibition in cigarette smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Follow-up study of early-life protective and risk factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Occupational exposures to metals as risk factors for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Smoking and Parkinson's disease: a dose-response relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Smoking and Parkinson's disease: a case-control study in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Parkinson's disease: a case-control study of occupational and environmental risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Epidemiologic study of Parkinson's disease in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Dithiocarbamates and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

The effect of diethyldithiocarbamate on the biodisposition of MPTP: an explanation for enhanced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Chronic nicotine treatment counteracts nigral cell loss induced by a partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Differential effects of acute and chronic nicotine treatment on MPTP-(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced degeneration of nigrostriatal dopamine neurons in the black mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Novel endogenous 1,2,3,4-tetrahydroisoquinoline derivatives: uptake by dopamine transporter and activity to induce parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Paraquat and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Environmental risk factors in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Does a long preclinical period occur in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

1‐Benzyl‐1,2,3,4‐Tetrahydroisoquinoline as a Parkinsonism‐Inducing Agent: A Novel Endogenous Amine in Mouse Brain and Parkinsonian CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

The next frontier in Parkinson's disease: presymptomatic detection

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Environmental risk factors and Parkinson's disease: a case-control study in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Presence of tetrahydroisoquinoline and 1-methyl-tetrahydro-isoquinoline in foods: Compounds related to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Risk of Parkinson's disease among first-degree relatives: A community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Environmental risk factors for Parkinson's disease in an urban multiethnic community

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Nicotine protects cultured striatal neurones against N-methyl-D-aspartate receptor-mediated neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Novel S-adenosylmethionine-dependent indole-N-methylation of beta-carbolines in brain particulate fractions.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Potential bioactivated neurotoxicants, N-methylated beta-carbolinium ions, are present in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

beta-Carbolinium cations, endogenous MPP+ analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Aging and Extrapyramidal Function

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate)

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Dopamine transporters and neuronal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Nicotine prevents glutamate-induced proteolysis of the microtubule-associated protein MAP-2 and glutamate neurotoxicity in primary cultures of cerebellar neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Risk-factors for Parkinson's disease: case-control study in the province of Cáceres, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Increased brain NAD prevents neuronal apoptosis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Transient severe parkinsonism after acute organophosphate poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Methyl-beta-carbolinium analogs of MPP+ cause nigrostriatal toxicity after substantia nigra injections in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Paraquat and two endogenous analogues of the neurotoxic substance N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine do not damage dopaminergic nigrostriatal neurons in the mouse.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Inhibition of mitochondrial electron transport by peroxynitrite

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Association of coffee and caffeine intake with the risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Paraquat and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Toxicity of dieldrin for dopaminergic neurons in mesencephalic cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

The catecholamine uptake blocker nomifensine protects against MPTP-induced parkinsonism in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Acute and persistent parkinsonism after use of diquat

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Parkinson's disease and exposure to rural environmental factors: a population based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Parkinson's disease and exposure to agricultural work and pesticide chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Parkinson's disease: a test of the multifactorial etiologic hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Carrier-mediated processes in blood--brain barrier penetration and neural uptake of paraquat

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Predicting Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

The epidemiology of Parkinson's disease. A case-control study of young-onset and old-onset patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Environmental factors and Parkinson's disease: a case-control study in China

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Parkinson disease in twins: an etiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Increased striatal dopamine turnover following acute administration of rotenone to mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

The tyramine-labelled vesicular transporter for dopamine: a putative target of pesticides and neurotoxins.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

(+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Caffeine mimics dopamine receptor agonists without stimulation of dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

No changes in behaviour, nigro-striatal system neurochemistry or neuronal cell death following toxic multiple oral paraquat administration to rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Environmental risk factors in siblings with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-813X%2802%2900099-2

7 January 2021

10.1016/S0161-813X(02)00099-2

Identifiers

DOI

1 reference

5 August 2017

1 reference